No. |
Variant name |
Chromosome position |
Chromatin state |
Related regulatory elements |
Target genes |
Extended variants |
Associated traits |
1 |
rs4803254 |
chr19:40004640-40004641 |
Weak transcription Bivalent Enhancer Bivalent/Poised TSS
|
TF binding regionChromatin interactive region
|
3 gene(s)
|
LD-proxies of rSNPOverlapped rCNV
|
mRNA abundance
|
2 |
rs536614351 |
chr19:40004683-40004684 |
Weak transcription Bivalent Enhancer Bivalent/Poised TSS
|
TF binding regionChromatin interactive region
|
3 gene(s)
|
Overlapped CNVs
|
n/a
|
3 |
rs564252584 |
chr19:40004688-40004689 |
Weak transcription Bivalent Enhancer Bivalent/Poised TSS
|
TF binding regionChromatin interactive region
|
3 gene(s)
|
Overlapped CNVs
|
n/a
|
4 |
rs536541321 |
chr19:40004714-40004715 |
Weak transcription Bivalent Enhancer Bivalent/Poised TSS
|
TF binding regionChromatin interactive region
|
3 gene(s)
|
Overlapped CNVs
|
n/a
|
5 |
rs377715543 |
chr19:40004720-40004721 |
Weak transcription Bivalent Enhancer Bivalent/Poised TSS
|
TF binding regionChromatin interactive region
|
3 gene(s)
|
Overlapped CNVs
|
n/a
|
6 |
rs76544036 |
chr19:40004909-40004910 |
Weak transcription Bivalent Enhancer Bivalent/Poised TSS
|
TF binding regionChromatin interactive region
|
3 gene(s)
|
Overlapped CNVs
|
n/a
|
7 |
rs78659295 |
chr19:40004918-40004919 |
Weak transcription Bivalent Enhancer Bivalent/Poised TSS
|
TF binding regionChromatin interactive region
|
3 gene(s)
|
Overlapped CNVs
|
n/a
|
8 |
rs556300916 |
chr19:40004939-40004940 |
Weak transcription Bivalent Enhancer Bivalent/Poised TSS
|
TF binding regionChromatin interactive region
|
3 gene(s)
|
Overlapped CNVs
|
n/a
|
9 |
rs578026402 |
chr19:40005029-40005030 |
Weak transcription Bivalent Enhancer Bivalent/Poised TSS
|
TF binding regionCpG islandChromatin interactive region
|
3 gene(s)
|
Overlapped CNVs
|
n/a
|
10 |
rs112129597 |
chr19:40005058-40005059 |
Weak transcription Bivalent Enhancer Bivalent/Poised TSS
|
TF binding regionChromatin interactive region
|
3 gene(s)
|
Overlapped CNVs
|
n/a
|
11 |
rs149885350 |
chr19:40005078-40005079 |
Weak transcription Bivalent Enhancer Bivalent/Poised TSS
|
TF binding regionChromatin interactive region
|
3 gene(s)
|
Overlapped CNVs
|
n/a
|
12 |
rs572349140 |
chr19:40005174-40005175 |
Weak transcription Bivalent Enhancer Bivalent/Poised TSS
|
TF binding regionChromatin interactive region
|
3 gene(s)
|
Overlapped CNVs
|
n/a
|
13 |
rs11667024 |
chr19:40005228-40005229 |
Flanking Bivalent TSS/Enh Active TSS Bivalent/Poised TSS Enhancers Bivalent Enhancer Weak transcription
|
TF binding regionChromatin interactive region
|
3 gene(s)
|
Overlapped CNVs
|
n/a
|
14 |
rs542889072 |
chr19:40005292-40005293 |
Flanking Bivalent TSS/Enh Active TSS Bivalent/Poised TSS Enhancers Bivalent Enhancer Weak transcription
|
TF binding regionChromatin interactive region
|
3 gene(s)
|
Overlapped CNVs
|
n/a
|
15 |
rs375527988 |
chr19:40005303-40005304 |
Flanking Bivalent TSS/Enh Active TSS Bivalent/Poised TSS Enhancers Bivalent Enhancer Weak transcription
|
TF binding regionChromatin interactive region
|
3 gene(s)
|
Overlapped CNVs
|
n/a
|
16 |
rs534794766 |
chr19:40005325-40005326 |
Flanking Bivalent TSS/Enh Active TSS Bivalent/Poised TSS Enhancers Bivalent Enhancer Weak transcription
|
TF binding regionChromatin interactive region
|
3 gene(s)
|
Overlapped CNVs
|
n/a
|
17 |
rs554402387 |
chr19:40005352-40005353 |
Flanking Bivalent TSS/Enh Active TSS Bivalent/Poised TSS Enhancers Bivalent Enhancer Weak transcription
|
TF binding regionChromatin interactive region
|
4 gene(s)
|
Overlapped CNVs
|
n/a
|
18 |
rs576677905 |
chr19:40005394-40005395 |
Flanking Bivalent TSS/Enh Active TSS Bivalent/Poised TSS Enhancers Bivalent Enhancer Weak transcription
|
TF binding regionChromatin interactive region
|
4 gene(s)
|
Overlapped CNVs
|
n/a
|
19 |
rs543377893 |
chr19:40005406-40005407 |
Bivalent/Poised TSS Flanking Bivalent TSS/Enh Flanking Active TSS Active TSS Bivalent Enhancer Enhancers
|
TF binding regionChromatin interactive region
|
4 gene(s)
|
Overlapped CNVs
|
n/a
|
20 |
rs564728705 |
chr19:40005442-40005443 |
Bivalent/Poised TSS Flanking Bivalent TSS/Enh Flanking Active TSS Active TSS Bivalent Enhancer Enhancers
|
TF binding regionChromatin interactive region
|
4 gene(s)
|
Overlapped CNVs
|
n/a
|
21 |
rs532193453 |
chr19:40005465-40005466 |
Bivalent/Poised TSS Flanking Bivalent TSS/Enh Flanking Active TSS Active TSS Bivalent Enhancer Enhancers
|
TF binding regionChromatin interactive region
|
4 gene(s)
|
Overlapped CNVs
|
n/a
|
22 |
rs10410648 |
chr19:40005516-40005517 |
Bivalent/Poised TSS Flanking Bivalent TSS/Enh Flanking Active TSS Active TSS Bivalent Enhancer Enhancers
|
TF binding regionChromatin interactive region
|
4 gene(s)
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
23 |
rs559585403 |
chr19:40005517-40005518 |
Bivalent/Poised TSS Flanking Bivalent TSS/Enh Flanking Active TSS Active TSS Bivalent Enhancer Enhancers
|
TF binding regionChromatin interactive region
|
4 gene(s)
|
Overlapped CNVs
|
n/a
|
24 |
rs529943876 |
chr19:40005532-40005533 |
Bivalent/Poised TSS Flanking Bivalent TSS/Enh Flanking Active TSS Active TSS Bivalent Enhancer Enhancers
|
TF binding regionChromatin interactive region
|
4 gene(s)
|
Overlapped CNVs
|
n/a
|
25 |
rs77098486 |
chr19:40005539-40005540 |
Bivalent/Poised TSS Flanking Bivalent TSS/Enh Flanking Active TSS Active TSS Bivalent Enhancer Enhancers
|
TF binding regionChromatin interactive region
|
4 gene(s)
|
Overlapped CNVs
|
n/a
|
26 |
rs569900683 |
chr19:40005603-40005604 |
Bivalent/Poised TSS Active TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Flanking Active TSS Enhancers
|
TF binding regionCpG islandChromatin interactive region
|
4 gene(s)
|
Overlapped CNVs
|
n/a
|
27 |
rs140724420 |
chr19:40005611-40005612 |
Bivalent/Poised TSS Active TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Flanking Active TSS Enhancers
|
TF binding regionCpG islandChromatin interactive region
|
4 gene(s)
|
Overlapped CNVs
|
n/a
|
28 |
rs115973004 |
chr19:40005615-40005616 |
Bivalent/Poised TSS Active TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Flanking Active TSS Enhancers
|
TF binding regionCpG islandChromatin interactive region
|
4 gene(s)
|
Overlapped CNVs
|
n/a
|
29 |
rs35235108 |
chr19:40005630-40005631 |
Bivalent/Poised TSS Active TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Flanking Active TSS Enhancers
|
TF binding regionCpG islandChromatin interactive region
|
4 gene(s)
|
Overlapped CNVs
|
n/a
|
30 |
rs77393823 |
chr19:40005635-40005636 |
Bivalent/Poised TSS Active TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Flanking Active TSS Enhancers
|
TF binding regionCpG islandChromatin interactive region
|
4 gene(s)
|
Overlapped CNVs
|
n/a
|
31 |
rs571589792 |
chr19:40005659-40005660 |
Bivalent/Poised TSS Active TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Flanking Active TSS Enhancers
|
TF binding regionCpG islandChromatin interactive region
|
4 gene(s)
|
Overlapped CNVs
|
n/a
|
32 |
rs538741844 |
chr19:40005679-40005680 |
Bivalent/Poised TSS Active TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Flanking Active TSS Enhancers
|
TF binding regionCpG islandChromatin interactive region
|
4 gene(s)
|
Overlapped CNVs
|
n/a
|
33 |
rs553874104 |
chr19:40005695-40005696 |
Bivalent/Poised TSS Active TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Flanking Active TSS Enhancers
|
TF binding regionCpG islandChromatin interactive region
|
4 gene(s)
|
Overlapped CNVs
|
n/a
|
34 |
rs548145137 |
chr19:40005709-40005710 |
Bivalent/Poised TSS Active TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Flanking Active TSS Enhancers
|
TF binding regionCpG islandChromatin interactive region
|
4 gene(s)
|
Overlapped CNVs
|
n/a
|
35 |
rs372238324 |
chr19:40005712-40005713 |
Bivalent/Poised TSS Active TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Flanking Active TSS Enhancers
|
TF binding regionCpG islandChromatin interactive region
|
4 gene(s)
|
Overlapped CNVs
|
n/a
|
36 |
rs565919445 |
chr19:40005736-40005737 |
Bivalent/Poised TSS Active TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Flanking Active TSS Enhancers
|
TF binding regionCpG islandChromatin interactive region
|
4 gene(s)
|
Overlapped CNVs
|
n/a
|
37 |
rs536413308 |
chr19:40005837-40005838 |
Bivalent/Poised TSS Active TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Enhancers Flanking Active TSS
|
TF binding regionCpG islandChromatin interactive region
|
4 gene(s)
|
Overlapped CNVs
|
n/a
|
38 |
rs554886244 |
chr19:40005855-40005856 |
Bivalent/Poised TSS Active TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Enhancers Flanking Active TSS
|
TF binding regionCpG islandChromatin interactive region
|
4 gene(s)
|
Overlapped CNVs
|
n/a
|
39 |
rs576629288 |
chr19:40005856-40005857 |
Bivalent/Poised TSS Active TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Enhancers Flanking Active TSS
|
TF binding regionCpG islandChromatin interactive region
|
4 gene(s)
|
Overlapped CNVs
|
n/a
|
40 |
rs543769850 |
chr19:40005866-40005867 |
Bivalent/Poised TSS Active TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Enhancers Flanking Active TSS
|
TF binding regionCpG islandChromatin interactive region
|
4 gene(s)
|
Overlapped CNVs
|
n/a
|
41 |
rs76140888 |
chr19:40005903-40005904 |
Bivalent/Poised TSS Active TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Enhancers Flanking Active TSS
|
TF binding regionChromatin interactive region
|
4 gene(s)
|
Overlapped CNVs
|
n/a
|
42 |
rs376284154 |
chr19:40005935-40005936 |
Bivalent/Poised TSS Active TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Enhancers Flanking Active TSS
|
TF binding regionChromatin interactive region
|
4 gene(s)
|
Overlapped CNVs
|
n/a
|
43 |
rs187415319 |
chr19:40005936-40005937 |
Bivalent/Poised TSS Active TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Enhancers Flanking Active TSS
|
TF binding regionChromatin interactive region
|
4 gene(s)
|
Overlapped CNVs
|
n/a
|
44 |
rs541106632 |
chr19:40005942-40005943 |
Bivalent/Poised TSS Active TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Enhancers Flanking Active TSS
|
TF binding regionChromatin interactive region
|
4 gene(s)
|
Overlapped CNVs
|
n/a
|
45 |
rs375911338 |
chr19:40005960-40005961 |
Bivalent/Poised TSS Active TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Enhancers Flanking Active TSS
|
TF binding regionChromatin interactive region
|
4 gene(s)
|
Overlapped CNVs
|
n/a
|
46 |
rs372527012 |
chr19:40005981-40005982 |
Bivalent/Poised TSS Active TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Enhancers Flanking Active TSS
|
TF binding regionChromatin interactive region
|
4 gene(s)
|
Overlapped CNVs
|
n/a
|
47 |
rs566071020 |
chr19:40006064-40006065 |
Bivalent/Poised TSS Active TSS Flanking Bivalent TSS/Enh Transcr. at gene 5' and 3' Bivalent Enhancer Flanking Active TSS Enhancers
|
TF binding regionChromatin interactive region
|
4 gene(s)
|
Overlapped CNVs
|
n/a
|
48 |
rs375570045 |
chr19:40006084-40006085 |
Bivalent/Poised TSS Active TSS Flanking Bivalent TSS/Enh Transcr. at gene 5' and 3' Bivalent Enhancer Flanking Active TSS Enhancers
|
TF binding regionChromatin interactive region
|
4 gene(s)
|
Overlapped CNVs
|
n/a
|
49 |
rs77624079 |
chr19:40006090-40006091 |
Bivalent/Poised TSS Active TSS Flanking Bivalent TSS/Enh Transcr. at gene 5' and 3' Bivalent Enhancer Flanking Active TSS Enhancers
|
TF binding regionChromatin interactive regionlncRNA
|
4 gene(s)
|
Overlapped CNVs
|
n/a
|
50 |
rs191574540 |
chr19:40006156-40006157 |
Bivalent/Poised TSS Active TSS Flanking Bivalent TSS/Enh Transcr. at gene 5' and 3' Bivalent Enhancer Flanking Active TSS Enhancers
|
TF binding regionChromatin interactive regionlncRNA
|
4 gene(s)
|
Overlapped CNVs
|
n/a
|